12-1831376-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001039029.3(LRTM2):āc.509C>Gā(p.Ser170Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000843 in 1,613,910 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 33)
Exomes š: 0.000091 ( 0 hom. )
Consequence
LRTM2
NM_001039029.3 missense
NM_001039029.3 missense
Scores
1
7
10
Clinical Significance
Conservation
PhyloP100: 3.04
Genes affected
LRTM2 (HGNC:32443): (leucine rich repeats and transmembrane domains 2) Predicted to enable Roundabout binding activity and heparin binding activity. Predicted to be involved in axon guidance and negative chemotaxis. Predicted to act upstream of or within positive regulation of synapse assembly. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
CACNA2D4 (HGNC:20202): (calcium voltage-gated channel auxiliary subunit alpha2delta 4) This gene encodes a member of the alpha-2/delta subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. Research on a highly similar protein in rabbit suggests the protein described in this record is cleaved into alpha-2 and delta subunits. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAdExome4 at 133 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRTM2 | NM_001039029.3 | c.509C>G | p.Ser170Trp | missense_variant | 4/5 | ENST00000299194.6 | NP_001034118.1 | |
CACNA2D4 | NM_172364.5 | c.2551+9363G>C | intron_variant | ENST00000382722.10 | NP_758952.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRTM2 | ENST00000299194.6 | c.509C>G | p.Ser170Trp | missense_variant | 4/5 | 2 | NM_001039029.3 | ENSP00000299194.1 | ||
CACNA2D4 | ENST00000382722.10 | c.2551+9363G>C | intron_variant | 1 | NM_172364.5 | ENSP00000372169.4 | ||||
CACNA2D4 | ENST00000586184.5 | c.2551+9363G>C | intron_variant | 5 | ENSP00000465060.1 | |||||
CACNA2D4 | ENST00000587995.5 | c.2476+9363G>C | intron_variant | 5 | ENSP00000465372.1 | |||||
CACNA2D4 | ENST00000585708.5 | c.2359+9363G>C | intron_variant | 5 | ENSP00000467697.1 | |||||
CACNA2D4 | ENST00000588077.5 | c.2359+9363G>C | intron_variant | 5 | ENSP00000468530.1 | |||||
CACNA2D4 | ENST00000444595.6 | n.*797+9363G>C | intron_variant | 1 | ENSP00000403371.2 | |||||
CACNA2D4 | ENST00000537784.5 | n.391+9363G>C | intron_variant | 1 | ENSP00000440231.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152218Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
3
AN:
152218
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251250Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135848
GnomAD3 exomes
AF:
AC:
8
AN:
251250
Hom.:
AF XY:
AC XY:
3
AN XY:
135848
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000910 AC: 133AN: 1461692Hom.: 0 Cov.: 31 AF XY: 0.0000798 AC XY: 58AN XY: 727170
GnomAD4 exome
AF:
AC:
133
AN:
1461692
Hom.:
Cov.:
31
AF XY:
AC XY:
58
AN XY:
727170
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74360
GnomAD4 genome
AF:
AC:
3
AN:
152218
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
74360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
2
ExAC
AF:
AC:
4
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 18, 2023 | The c.509C>G (p.S170W) alteration is located in exon 4 (coding exon 2) of the LRTM2 gene. This alteration results from a C to G substitution at nucleotide position 509, causing the serine (S) at amino acid position 170 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
D
M_CAP
Uncertain
D
MetaRNN
Uncertain
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Uncertain
Sift
Benign
D;D;D
Sift4G
Benign
T;T;T
Polyphen
D;D;D
Vest4
MutPred
Loss of disorder (P = 0);Loss of disorder (P = 0);Loss of disorder (P = 0);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at